We investigated the expression of calcium-dependent phospholipid binding protein annexin-II (Ann-II) messenger RNA (mRNA) during preantral follicle development and in oocytes from antral follicles of different diameters (< 3 mm, 5 to 8 mm and > 8 mm). The action of retinol on Ann-II mRNA expression in mature oocytes was also examined. Only oocytes from secondary preantral follicles expressed Ann-II mRNA and at the germinal vesicle stage expression by oocytes from follicles larger than 8 mm was significantly higher (p < 0.05) compared with oocytes from follicles smaller than 3 mm or between 5 and 8 mm. Ann-II mRNA expression by metaphase II oocytes from follicles larger than 8 mm was significantly higher (p < 0.05) than that from oocytes from follicles smaller than 3 mm, with oocytes from both these size-classes showing similar levels of Ann-II mRNA expression as oocytes recovered from 5-8 mm follicles. In the presence of retinol, Ann-II mRNA expression was higher than when retinol was absent (p < 0.05). Our data indicate that Ann-II mRNA expression is highest in competent oocytes and that retinol increases Ann-II mRNA and may be involved in the regulation of oocyte competence by decreasing the translation and/or degradation of Ann-II mRNA.
Introduction
The kinetics of the nuclear maturation of bovine oocytes have been extensively studied (Sirard et al. 1989; Süss et al. 1988) . Bovine oocytes acquire the competence for resuming and completing meiosis after the follicle reaches between 1.7 and 2.0 mm in diameter, a stage in which the oocyte has fully developed and measures 150 µm (Motlik and Kubelka, 1990) . The key regulator in the cell cycle for both meiosis and mitosis is maturation-promoting factor, a serine/threonine kinase protein composed of one catalytic sub-unit (p34 cdc2 ) and one regulator sub-unit (B cyclin; Lohka et al. 1988) . The active form of maturation-promoting factor induces the disintegration of the nuclear membrane, directing several events such as germinal vesicle breakdown, chromosome condensation, and reorganization of the cytoplasm during meiosis and mitosis (Parrish et al. 1992) . Oocytes have very low levels of p34 cdc2 during development and are unable to progress from the G2 to the M phase of meiosis but at the end of the developmental stage the concentration and activity of p34 cdc2 are high and the oocyte then acquires meiotic competence (Wu et al. 1997) . Greater maturation-promoting factor expression and activity during follicle growth suggests that the proteins involved in the regulation of meiosis have similar expression profiles.
Annexin-II (Ann-II) is a calcium-dependent phospholipid binding protein, significantly expressed in various epithelial tissues (intestine, lungs, vascular endothelium, endometrium and ovaries) (Dreier et al. 1998) . This protein plays a regulatory role in exocytosis, endocytosis, plasminogen activation, cell adhesion (Brownstein et al. 2004; Fitzpatrick et al. 2000) , immunoglobulin transport (Kristoffersen and Matre, 1996) and ion channel activity (Burger et al. 1996) . Ann-II forms an active tetrameric complex with S-100 protein sub-type A10 (S-100A10, also known as protein p11), the S-100 protein being known to be involved in cell-cycle regulation (Cajone and Sherbet, 1999) . Costa (1999) used immunohistochemical analyses to detected the S-100 protein in preantral and antral follicle oocytes from cows and cow fetuses and although the specific S-100 subtype was not studied these results imply that protein p11 could be present, suggesting that Ann-II may regulate growth and maturation in oocytes during follicular development.
Retinol (vitamin A) participates in the normal development of young animal tissues, acting via growth factors such as epidermal growth factor (Wolf, 1984) . Ann-II gene expression can be regulated by retinol, suggesting that genes that are activated by retinol-binding retinoic acid receptors may play an important role in the survival of the oogonium and the oocyte and the prevention of apoptosis (Wolf, 1984) .
During the study described in this paper we investigated the expression of Ann-II mRNA in preantral follicles and oocytes from antral follicles at different developmental stages. We also assessed the effects of retinol on Ann-II mRNA expression in mature oocytes.
Material and Methods

Oocyte collection and preparation
For collection of oocytes from primordial, primary or secondary follicles ovaries were collected from bovine fetuses obtained from cows (Bos taurus taurus) slaughtered at an abattoir in the town of Santa Maria in the Brazilian state of Rio Grande do Sul, Brazil. The fetuses were calculated to be 210 to 240 days old based on the method of Rüsse (1983) , which correlates the cranio-caudal length of the fetus to pregnancy time in days. The ovaries were transported to our laboratory in TCM199 culture medium (Gibco, United States) at 30°C in an isothermic container and preantral follicles isolated by mechanical dissociation (Figueiredo et al. 1993 as modified by Carámbula et al., 1999) . Follicles were designated as primordial, primary or secondary according to their size as measured using an inverted microscope equipped with a micrometer (Hulshof et al., 1994) . One hundred follicles from each size-class were pooled for messenger RNA (mRNA) extraction and PCR detection of complementary (cDNA).
Tertiary follicle oocytes were collected from ovaries obtained from the same abattoir and were transferred to our laboratory in the same manner as the other ovaries except that in this case the transport medium was 0.9% NaCl. In the laboratory, the ovaries were washed twice in 0.9% NaCl and then kept in a double bath at 30°C until needed. Follicles of different sizes (less than 3 mm, between 5 and 8 mm and larger than 8 mm in diameter) were individually aspired to collect grade I (Leibfried and First 1979) oocytecumulus complexes (COCs,) which were characterized as compact cumulus, complete cumulus, and oocyte with homogeneous cytoplasm.
Non-matured COCs of each follicle size-category were mechanically agitated to disrupt the cumulus cells and the denuded oocytes washed twice with TCM199 medium supplemented with Earle salts, L-glutamine, 25 mM Hepes (Sigma), 0.2 mM sodium pyruvate, 100 IU penicillin mL . A set of 10 oocytes per follicle category was used for maturation in three replicates.
Immature COCs from different follicle categories were cultured in TCM199 medium supplemented with Earle salts, L-glutamine, 25 mM Hepes (Sigma), 0.2 mM sodium pyruvate, 26.19 mM sodium bicarbonate, 100 IU penicillin mL -1 , 50 µg streptomycin mL -1 and 1.0 mg PVA mL -1 (TCM-PVA) for 24 h at 39°C in a 5% CO 2 saturated humidity atmosphere before being mechanically agitated to disrupt the cumulus cells, the denuded oocytes being washed twice in TCM199/(TCM-PVA). The state and category of the mature oocytes was checked by microscopy by mounting a set of oocytes from each of the follicle categories on slides, fixing them with acetic acid:methanol (1:3 v/v) for 24 h and staining them with 1% (w/v) Lacmoid in 45% acetic acid diluted with phosphate-buffered saline (PBS) (Vignola et al. 1994 ).
Retinol addition during maturation
Immature COCs from tertiary follicle were obtained and cultured in the same conditions of the experiment described above. The COCs were randomly divided into control and treatment group. In the control group, the oocytes were matured in TCM199 medium supplemented with Earle salts, L-glutamine, 25 mM Hepes (Sigma), 0.2 mM sodium pyruvate, 26.19 mM sodium bicarbonate, 100 IU penicillin mL -1 , 50 µg streptomycin mL -1 and 1.0 mg PVA mL -1 (TCM-PVA maturation medium) for 24 h at 39°C in a 5% CO 2 saturated humidity atmosphere. In the treatment group, the oocytes were incubated under the same conditions, but the TCM-PVA maturation medium was supplemented with 1 ng of retinol/mL -1 . Ten oocytes per group were used for maturation in three replicates. After maturation, the oocytes were submitted to a semiquantitative analysis for Ann-II mRNA expression.
Extraction of mRNA
We extracted mRNA from preantral follicles and oocytes using the Rneasy® Mini kit (QIAGEN Inc., Chatsworth, CA, USA). Briefly, after successive washes in PBS the preantral follicles and oocytes were transferred to a 1.5-mL centrifuge tube containing 350 µL RLT buffer (Qiagen, United States), plus 3.5 µL of β-mercaptoethanol and mechanically shaken for 15 s before adding 350 µL of aqueous ethanol (70% v/v). The homogenized contents of the tube were transferred to an mRNA extraction minicolumn which was centrifuged for 15 s at 8000 g, after which 700 µL of RW1 buffer (Qiagen, United States) was added and the column centrifuged as above and then washed twice with 500 µL of a 1:4 (v/v) mixture of RPE buffer (Qiagen, United States) and anhydrous ethanol and then centrifuged for 2 min at 8000 g to totally dry the column. The dry column was transferred to a new centrifuge tube containing 40 µL of ultrapure water and the tube centrifuged for 1 min at 8000 g to dilute the mRNA.
Complementary DNA (cDNA) synthesis and PCR amplification
We produced complementary DNA (cDNA) using a commercial kit (Sensiscript TM Reverse Transcriptase (RT) kit, QIAGEN Inc., Chatsworth, CA, USA), each RT-PCR mixture containing 2.0 µL buffer, 2.0 µL dNTP, 2.0 µL oligoDT-primer, 0.25 µ Rnase inhibitor, 1.0 µL Sensiscript enzyme, and 12.5 µL of the mRNA extraction product. The reaction was carried out in a thermocycler at 37°C for 1 h and the reaction product containing cDNA was stored at -18°C until use.
Ann-II cDNA was amplified by PCR using a primer (forward 5'CCTCCAAGTGCA TACGGG3' and reverse 5'TCATACTGAGCAGGTGTTTT3') produced by Invitrogen Life Technologies (USA) and a primer (forward 5'TGTTCCAGTATGA TTCCACCC3' and reverse 5'TC CACCACCCTGTTGCTGTA3') for the constitutive enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a positive control to ensure that cRNA had indeed been extracted. The PCR cDNA amplification mixture contained 17.5 µL ultrapure water, 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 250 µM of each dNTP, 0.4 µM of each primer, 2.5 U Taq DNA polymerase and 3µL of cDNA in a final volume of 25 µL. Amplification was performed in a thermocycler under the following conditions: step 1, 94°C for 5 min; step 2, 94°C for 1 min; step 3, 60°C for 1 min for the Ann-II primers or 54°C for 45 s for the GAPDH primers; step 4, 72°C for 1 min; step 5, a final extension at 72°C for 5 min. Steps 2-4 were repeated for 34 cycles for Ann-II and 31 cycles for GAPDH. The relative amount of transcript was compared between groups based on the amplification results by comparing the constitutive GAPDH gene and the Ann-II gene. The PCR products were separated on 2% (w/v) agarose gel in pH 8.0 Tris, boric acid EDTA buffer (TBE, containing 0.09 M Tris, 0.09 M boric acid and 0.5 M EDTA), stained with ethidium bromide and visualized under ultraviolet light. The data for semi-quantitative analysis of gene expression were obtained by capturing the gel images with a digital camera and recording them with the Alpha DigiDoc 1000 program to obtain arbitrary values. The arbitrary values were obtained using GAPDH as an internal control in each group of oocytes from different class-size.
To ensure that mRNA extraction and cDNA amplification were effective only samples in which GAPDH mRNA was detected were used in the analyses. Expression of Ann II mRNA in preantral follicles at different stages of development was assessed only as presence or absence of expression and no statistical analysis was performed. The semi-quantitative expression of Ann II mRNA based on arbitrary values were subjected to analysis of variance (ANOVA).
Results and Discussion
We observed expression of Ann-II in secondary follicles but not primordial and primary follicles, this being the first report of Ann-II expression in bovine preantral follicles. Preantral follicles express several proteins important for follicle and oocyte development (van Wezel and Rogers, 1996) but the factors and underlying mechanism involved in primordial follicle activation are not yet completely understood. Our data indicates that Ann-II is probably not involved in the activation of primordial follicles because it was not detected in the early stages of follicular development. We detected GAPDH mRNA, indicating that mRNA was indeed being detected, and this was used as the control in the assessment of the Ann-II gene expression in oocytes from different follicle sizes.
At the germinal vesicle stage, oocytes from different follicle sizes were mutually different (p < 0.05) regarding the expression of Ann-II mRNA. Oocytes recovered from follicles smaller than 3 mm or between 5 and 8 mm showed significantly (p < 0.05) lower Ann-II mRNA expression as compared with oocytes from follicles larger than 8 mm (Figure 1 ), suggesting that Ann-II plays a positive role in the processes of oocyte competence and capacity. It is known that oocytes remain in the first meiotic division prophase up until a little before ovulation and that the proteins responsible for the increase in size during this phase are synthesized during the oocyte growth phase (Mermillod et al., 1996) . Oocyte development is completed soon after the follicular antrum forms when oocytes acquire the competence necessary to restart the first meiotic division but not the complete capacity for embryo development (Sirard and First, 1988) . Our results showing significant expression of Ann-II mRNA by oocytes from follicles larger than 8 mm as compared to the smaller oocytes points to Ann-II as an important protein in oocyte capacity.
Metaphase II oocytes from follicles larger than 8 mm in diameter expressed significantly more (p < 0.05) Ann-II mRNA than oocytes from follicles smaller than 3 mm, with oocytes from both these size-classes showing similar levels of Ann-II mRNA expression as oocytes recovered from 5-8 mm follicles (Figure 1) .
These data reinforce the evidence that Ann-II may be involved in the process of oocytes capacity, since oocytes from follicles larger than 8 mm are more capable of reaching the blastocyst stage as compared with oocytes from smaller follicles.
Retinol has been tested for its ability to regulate protein synthesis in several tissues in different species (Wolf, 1984) . When retinol was present during maturation there was a significant increase (p < 0.05) in Ann-II mRNA levels as compared to controls without retinol (Figure 2 ). Since gene expression occurs only during the first hour of matura- 398 Annexin II in bovine oocytes tion, our results indicate that retinol may either have increased transcription at the beginning of maturation or lessened the degradation of Ann-II mRNA. Although retinol does not affect the kinetics of oocyte maturation, it has been confirmed that it can significantly increase the rate of cell cleavage in a chemically defined environment (Bortolotto et al. 2001) . It is also possible that retinol is capable of modifying gene expression or translation during maturation, which could influence fertilization capacity and embryo development. The resumption and progression of meiosis depends on intracellular oscillations in calcium levels (Kline, 1996) which induces the degradation of maturation-promoting factor, a single Ca + oscillation being enough to bring about germinal vesicle breakdown (Wu et al. 1997) . Ann-II is a protein that takes part in the activity of oocyte calcium channels (Dreier et al. 1998 ) and may be an important factor in oocyte competence and capacity.
In summary, we detected higher levels of Ann-II mRNA in capacitated oocytes as compared to uncapacitated oocytes. We also found that retinol increased Ann-II mRNA levels and may be involved in the regulation of oocyte competence by increasing translation or preventing degradation. 
